4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 January 1, 2018 Swift Biosciences Doubles Michigan HQ Space And Opens Up Shop In San Francisco October 5, 2017 This Drug Could be the Most Crucial in Regeneron's Massive Pipeline August 22, 2017
